Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Mallinckrodt
Cerilliant
Chinese Patent Office
Dow
US Army
Fish and Richardson
Colorcon
Baxter
Citi

Generated: February 23, 2018

DrugPatentWatch Database Preview

Alvogen Malta Company Profile

« Back to Dashboard

What is the competitive landscape for ALVOGEN MALTA, and what generic and branded alternatives to ALVOGEN MALTA drugs are available?

ALVOGEN MALTA has twenty-seven approved drugs.



Summary for Alvogen Malta
US Patents:0
Tradenames:25
Ingredients:22
NDAs:27

Drugs and US Patents for Alvogen Malta

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen Malta FELBAMATE felbamate TABLET;ORAL 204595-001 Jan 11, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Alvogen Malta MACRODANTIN nitrofurantoin, macrocrystalline CAPSULE;ORAL 016620-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-004 Apr 9, 1990 AB RX Yes No ➤ Sign Up ➤ Sign Up
Alvogen Malta DISULFIRAM disulfiram TABLET;ORAL 091681-001 Aug 8, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Alvogen Malta TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984 AB RX Yes Yes ➤ Sign Up ➤ Sign Up
Alvogen Malta ZESTRIL lisinopril TABLET;ORAL 019777-006 Jan 20, 1999 AB RX Yes No ➤ Sign Up ➤ Sign Up
Alvogen Malta OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 202116-001 Dec 30, 2011 AB RX No No ➤ Sign Up ➤ Sign Up
Alvogen Malta ZESTORETIC hydrochlorothiazide; lisinopril TABLET;ORAL 019888-003 Nov 18, 1993 AB RX Yes No ➤ Sign Up ➤ Sign Up
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up
Alvogen Malta ZESTRIL lisinopril TABLET;ORAL 019777-005 Apr 29, 1993 AB RX Yes No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Alvogen Malta

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta ZESTORETIC hydrochlorothiazide; lisinopril TABLET;ORAL 019888-002 Jul 20, 1989 4,374,829*PED ➤ Sign Up
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-004 Apr 9, 1990 3,836,671 ➤ Sign Up
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982 3,934,032 ➤ Sign Up
Alvogen Malta MACROBID nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 020064-001 Dec 24, 1991 4,772,473 ➤ Sign Up
Alvogen Malta SPECTAZOLE econazole nitrate CREAM;TOPICAL 018751-001 Dec 23, 1982 3,839,574 ➤ Sign Up
Alvogen Malta TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984 3,836,671 ➤ Sign Up
Alvogen Malta ZESTORETIC hydrochlorothiazide; lisinopril TABLET;ORAL 019888-003 Nov 18, 1993 4,374,829*PED ➤ Sign Up
Alvogen Malta TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 3,663,607 ➤ Sign Up
Alvogen Malta TENORETIC 50 atenolol; chlorthalidone TABLET;ORAL 018760-002 Jun 8, 1984 3,934,032 ➤ Sign Up
Alvogen Malta ZESTRIL lisinopril TABLET;ORAL 019777-002 May 19, 1988 4,374,829*PED ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
QuintilesIMS
Merck
Queensland Health
UBS
US Army
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot